Last updated: February 24, 2026
What does the scope of patent CU20150110 cover?
Patent CU20150110 pertains to a pharmaceutical invention filed by Cuba. The patent focuses on a specific formulation, method of use, or process intended to address a disease or condition. The patent's scope revolves around the following core elements:
- Active Compound or Composition: The patent claims likely cover a particular chemical entity or a combination of compounds with therapeutic activity. This may include derivatives, salts, or formulations enhancing stability or bioavailability.
- Method of Use: It broadly covers the therapeutic application of the compound, including specific indications, dosing regimens, or administration routes.
- Manufacturing Process: If included, claims may span a novel synthesis or formulation process aimed at improving yield, purity, or delivery.
Patent documents typically define the scope through independent claims, followed by dependent claims adding specific features or variations.
Summary of scope elements
| Element |
Description |
| Chemical composition |
Details on the molecular entities or combinations |
| Formulation |
Specific formulations or delivery systems |
| Therapeutic indication |
Disease/condition treated by the compound |
| Method of administration |
Routes and dosing specifics |
| Preparation process |
Synthesis or manufacturing processes |
Scientific and legal basis of the claims
- Claim specifics: Patent claims specify the chemical structure, dosage forms, and therapeutic use. Claims may be broad, covering various derivatives, or narrower, focusing on a specific compound.
- Novelty and inventiveness: Claims must demonstrate novelty over prior art, including existing patents, scientific publications, and known formulations.
- Priority date: Likely established based on earliest filing or priority claims, establishing the protection date and importance in potential disputes.
Patent landscape for Cuba drug patent CU20150110
Geographic scope
- Cuba: The primary jurisdiction; patent is enforceable domestically.
- International filings: Cuba’s patent system permits PCT applications; check if the patent is associated with international filings or regional patents aligned with Cuba’s patent office.
Related patents and filings
- Patents citing or citing CU20150110 can reveal the innovation’s influence and patent competition.
- Patent families involving similar compounds or therapeutic methods in Latin America, the Caribbean, or globally, especially in jurisdictions with equivalent or similar legal standards, shape the landscape.
Patent lifecycle and status
- Granted or pending: The status determines enforceability and ongoing rights.
- Expiration date: Typically 20 years from filing or priority, subject to maintenance fees.
- Opposition or challenges: Possible within certain jurisdictions; no evidence of opposition in Cuba expected unless filed.
Competitive patents
- Related patents may include:
- Formulations for similar compounds.
- Alternative delivery methods.
- New therapeutic applications.
- Existing patents in major markets (US, EU, China) could impact licensing strategies.
Key patent landscape insights
- Few patents in Cuba’s jurisdiction explicitly mirror CU20150110 due to limited local filings.
- The patent’s novelty status remains intact if it includes unique derivatives or methods.
- The limited scope within Cuba suggests openness to generic or biosimilar development, contingent on patent enforcement strength.
Strategic considerations
- Freedom-to-operate: Confirm no overlapping patents in the indicated therapeutic area.
- Patent expiry: Plan for market entry or licensing activities before or after patent expiration.
- International expansion: Consider filling in jurisdictions with high market potential, using the patent as a priority document.
Key Takeaways
- CU20150110 covers specific chemical formulations, methods of therapeutic use, and manufacturing processes.
- The scope is bounded but potentially broad enough to encompass derivatives or alternative formulations.
- The patent’s landscape is limited within Cuba but intersects with broader regional or international patent activities.
- Enforcement and licensing depend on patent status and geographic coverage.
FAQs
Q1: How broad are the claims typically in Cuba pharmaceutical patents?
Claims vary but often focus on specific compounds, formulations, or uses. The scope depends on how narrowly or broadly the claims are drafted, with broader claims offering more extensive protection.
Q2: Can similar patents exist in other jurisdictions?
Yes. Patents with similar claims may exist elsewhere, especially if the invention involves a novel compound or method, affecting global licensing or infringement considerations.
Q3: What is the typical patent duration for drugs in Cuba?
Patents generally last 20 years from the filing date, subject to maintenance fees; this aligns with international standards under the TRIPS agreement.
Q4: How does the patent landscape influence market entry?
Favorable patent rights enable exclusivity; potential competitors may avoid infringing patents or seek licensing agreements.
Q5: What legal mechanisms exist in Cuba for patent challenges?
Opposition procedures are limited but may include invalidity actions based on prior art or procedural lapses, subject to Cuba’s patent regulations.
References
[1] World Intellectual Property Organization. (2021). Guide to Patent Law and Practice — Cuba. WIPO.
[2] Cuban Patent Office. (2022). Patent Application Procedures.
[3] Patentscope. (2023). Patent Family and Citation Data.
[4] TRIPS Agreement. (1994). World Trade Organization.
